Cargando…
Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancer
Several recently reported evidence-based phase 3 trials that focus on the role of cytotoxic chemotherapy have the potential to strongly influence the care of women with advanced epithelial ovarian cancer. Particular areas of interest include: (a) neoadjuvant chemotherapy; (b) chemotherapy of recurre...
Autor principal: | Markman, Maurie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948379/ https://www.ncbi.nlm.nih.gov/pubmed/20948857 http://dx.doi.org/10.3410/M2-29 |
Ejemplares similares
-
Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
por: Markman, Maurie
Publicado: (2009) -
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
por: Markman, Maurie
Publicado: (2018) -
New developments in the anti-neoplastic drug management of ovarian cancer
por: Markman, Maurie
Publicado: (2013) -
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
por: Markman, Maurie
Publicado: (2011) -
Update on the utility of prognostic biomarkers in ovarian cancer
por: Markman, Maurie
Publicado: (2009)